These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11802382)

  • 41. Making degeneration specific.
    Narasimhan K
    Nat Med; 2001 Nov; 7(11):1184. PubMed ID: 11689879
    [No Abstract]   [Full Text] [Related]  

  • 42. [Spinocerebellar ataxia type 1 (SCA1)].
    Uchiyama T; Sakakibara R; Hattori T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):262-5. PubMed ID: 10434647
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cerebello-olivary atrophy (COA)].
    Mizusawa H
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):239-42. PubMed ID: 10434641
    [No Abstract]   [Full Text] [Related]  

  • 44. Comment: CAG repeats in idiopathic Parkinson disease-To screen or not to screen.
    Filla A
    Neurology; 2015 Oct; 85(15):1291. PubMed ID: 26354983
    [No Abstract]   [Full Text] [Related]  

  • 45. Repeat meeting's repeat performance. The Second International Conference on Unstable Microsatellites and Human Disease, Chapel Hill, North Carolina, USA, 17-20 April 1999.
    Sa Spada AR
    Trends Genet; 1999 Sep; 15(9):350-1. PubMed ID: 10532895
    [No Abstract]   [Full Text] [Related]  

  • 46. Polyglutamine tracts in schizophrenia: gaining new insights.
    Denghien I; Joober R; Rouleau GA; Néri C
    Mol Psychiatry; 2000 May; 5(3):236-7. PubMed ID: 10889523
    [No Abstract]   [Full Text] [Related]  

  • 47. Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells?
    Petronis A; Vincent JB; Surh LC; Ashizawa T; Kennedy JL
    Mol Psychiatry; 2000 May; 5(3):234-6. PubMed ID: 10889522
    [No Abstract]   [Full Text] [Related]  

  • 48. Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
    Mackenzie IR; Butland SL; Devon RS; Dwosh E; Feldman H; Lindholm C; Neal SJ; Ouellette BF; Leavitt BR
    BMC Neurol; 2006 Aug; 6():32. PubMed ID: 16945149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of polyglutamine-induced disease: A model for SCA1.
    Klement IA; Zoghbi HY; Orr HT
    Mol Genet Metab; 1999 Mar; 66(3):172-8. PubMed ID: 10066385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A SCA7 CAG/CTG repeat expansion is stable in Drosophila melanogaster despite modulation of genomic context and gene dosage.
    Jackson SM; Whitworth AJ; Greene JC; Libby RT; Baccam SL; Pallanck LJ; La Spada AR
    Gene; 2005 Feb; 347(1):35-41. PubMed ID: 15715978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A-overhang-dependent repeat expansion determination (ADRED).
    Achmüller C; Köhler A; Bösch S; Schneider R
    Biotechniques; 2008 Nov; 45(5):577-80. PubMed ID: 19007342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Candidate gene approach for polyglutamine disease: isolation and characterization of human brain cDNAs containing CAG repeats].
    Igarashi S; Amaya N; Tsuji S
    Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2295-8. PubMed ID: 11802382
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.